FindTrial
Sign In

Effects of NLRP3 on liver cirrhosis

Effects of NLRP3 on liver cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063108
Enrollment
Unknown
Registered
2022-08-31
Start date
2022-08-31
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis

Interventions

Liver cirrhosis group:N/A
Control group:N/A

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients that are planning to undergo partial liver resection.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
Expression levels of NLRP3 in liver;Level of liver fibrosis;—

Secondary

MeasureTime frame
Patient general condition;—

Countries

China

Contacts

Public ContactGao Jinhang

West China Hospital, Sichuan University

gao.jinhang@scu.edu.cn+86 19983137980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026